These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22725134)

  • 1. HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor β on genetically distinct surfaces.
    Hultquist JF; McDougle RM; Anderson BD; Harris RS
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1543-51. PubMed ID: 22725134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential requirements for HIV-1 Vif-mediated APOBEC3G degradation and RUNX1-mediated transcription by core binding factor beta.
    Du J; Zhao K; Rui Y; Li P; Zhou X; Zhang W; Yu XF
    J Virol; 2013 Feb; 87(3):1906-11. PubMed ID: 23175372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.
    Matsui Y; Shindo K; Nagata K; Yoshinaga N; Shirakawa K; Kobayashi M; Takaori-Kondo A
    J Biol Chem; 2016 Nov; 291(48):24892-24899. PubMed ID: 27758855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction.
    Zhang W; Du J; Evans SL; Yu Y; Yu XF
    Nature; 2011 Dec; 481(7381):376-9. PubMed ID: 22190036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CBFβ enhances de novo protein biosynthesis of its binding partners HIV-1 Vif and RUNX1 and potentiates the Vif-induced degradation of APOBEC3G.
    Miyagi E; Kao S; Yedavalli V; Strebel K
    J Virol; 2014 May; 88(9):4839-52. PubMed ID: 24522927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dispersed and conserved hydrophobic residues of HIV-1 Vif are essential for CBFβ recruitment and A3G suppression.
    Zhou X; Han X; Zhao K; Du J; Evans SL; Wang H; Li P; Zheng W; Rui Y; Kang J; Yu XF
    J Virol; 2014 Mar; 88(5):2555-63. PubMed ID: 24352440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a tripartite interaction between the N-terminus of HIV-1 Vif and CBFβ that is critical for Vif function.
    Desimmie BA; Smith JL; Matsuo H; Hu WS; Pathak VK
    Retrovirology; 2017 Mar; 14(1):19. PubMed ID: 28302150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection.
    Jäger S; Kim DY; Hultquist JF; Shindo K; LaRue RS; Kwon E; Li M; Anderson BD; Yen L; Stanley D; Mahon C; Kane J; Franks-Skiba K; Cimermancic P; Burlingame A; Sali A; Craik CS; Harris RS; Gross JD; Krogan NJ
    Nature; 2011 Dec; 481(7381):371-5. PubMed ID: 22190037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.
    Matsui Y; Shindo K; Nagata K; Io K; Tada K; Iwai F; Kobayashi M; Kadowaki N; Harris RS; Takaori-Kondo A
    Virology; 2014 Jan; 449():82-7. PubMed ID: 24418540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction.
    Duan S; Wang S; Song Y; Gao N; Meng L; Gai Y; Zhang Y; Wang S; Wang C; Yu B; Wu J; Yu X
    J Biol Chem; 2020 Oct; 295(43):14592-14605. PubMed ID: 32817167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Vif-Mediated Degradation of APOBEC3G through Competitive Binding of Core-Binding Factor Beta.
    Miyagi E; Welbourn S; Sukegawa S; Fabryova H; Kao S; Strebel K
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.
    Fribourgh JL; Nguyen HC; Wolfe LS; Dewitt DC; Zhang W; Yu XF; Rhoades E; Xiong Y
    J Virol; 2014 Mar; 88(6):3309-19. PubMed ID: 24390320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vif proteins of human and simian immunodeficiency viruses require cellular CBFβ to degrade APOBEC3 restriction factors.
    Hultquist JF; Binka M; LaRue RS; Simon V; Harris RS
    J Virol; 2012 Mar; 86(5):2874-7. PubMed ID: 22205746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant Negative Mutants of Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) Disrupt Core-Binding Factor Beta-Vif Interaction.
    Duan S; Yu X; Wang C; Meng L; Gai Y; Zhou Y; Gu T; Yu B; Wu J; Yu X
    J Virol; 2022 Sep; 96(17):e0055522. PubMed ID: 35950859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression.
    Kim DY; Kwon E; Hartley PD; Crosby DC; Mann S; Krogan NJ; Gross JD
    Mol Cell; 2013 Feb; 49(4):632-44. PubMed ID: 23333304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CBFß and HIV Infection.
    Kim DY; Gross JD
    Adv Exp Med Biol; 2017; 962():415-431. PubMed ID: 28299671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the interaction of full-length HIV-1 Vif protein with its key regulator CBFβ and CRL5 E3 ubiquitin ligase components.
    Zhou X; Evans SL; Han X; Liu Y; Yu XF
    PLoS One; 2012; 7(3):e33495. PubMed ID: 22479405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding.
    Mehle A; Wilson H; Zhang C; Brazier AJ; McPike M; Pery E; Gabuzda D
    J Virol; 2007 Dec; 81(23):13235-41. PubMed ID: 17898068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple lysines combined in HIV-1 Vif determines the responsiveness to CBF-β.
    Ai Y; Ma J
    Biochem Biophys Res Commun; 2015 Feb; 457(3):385-90. PubMed ID: 25582776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.
    Russell RA; Smith J; Barr R; Bhattacharyya D; Pathak VK
    J Virol; 2009 Feb; 83(4):1992-2003. PubMed ID: 19036809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.